Seminars in Ultrasound Ct and Mri最新文献

筛选
英文 中文
Imaging Assessment of Prostate Cancer Extra-prostatic Extension: From Histology to Controversies 前列腺癌前列腺外延伸的影像评估:从组织学到争议。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.003
Cecília Vidal de Souza Torres MD , Gabriel de Lion Gouvea MD , André de Freitas Secaf MD , David Freire Maia Vieira , Alexandre Souto de Moraes Morgado , Matheus de Moraes Palma MD , Gabriel Andrade Ramos MD , Jorge Elias Jr MD, PhD , Valdair F. Muglia MD, PhD
{"title":"Imaging Assessment of Prostate Cancer Extra-prostatic Extension: From Histology to Controversies","authors":"Cecília Vidal de Souza Torres MD ,&nbsp;Gabriel de Lion Gouvea MD ,&nbsp;André de Freitas Secaf MD ,&nbsp;David Freire Maia Vieira ,&nbsp;Alexandre Souto de Moraes Morgado ,&nbsp;Matheus de Moraes Palma MD ,&nbsp;Gabriel Andrade Ramos MD ,&nbsp;Jorge Elias Jr MD, PhD ,&nbsp;Valdair F. Muglia MD, PhD","doi":"10.1053/j.sult.2024.11.003","DOIUrl":"10.1053/j.sult.2024.11.003","url":null,"abstract":"<div><div>Prostate cancer (PCa) is the most common non-skin malignancy among men and the fourth leading cause of cancer-related deaths globally. Accurate staging of PCa, particularly the assessment of extra-prostatic extension (EPE), is critical for prognosis and treatment planning. EPE, typically evaluated using magnetic resonance imaging (MRI), is associated with higher risks of positive surgical margins, biochemical recurrence, metastasis, and reduced overall survival. Despite the widespread use of MRI, there is no consensus on diagnosing EPE via imaging. There are 2 main scores assessing EPE by MRI: the European Society of Urogenital Radiology score and an MRI-based EPE grading system from an American group. While both are widely recognized, their differences can lead to varying interpretations in specific cases. This paper clarifies the anatomical considerations in diagnosing locally advanced PCa, explores EPE’s impact on treatment and prognosis, and evaluates the relevance of MRI findings according to different criteria. Accurate EPE diagnosis remains challenging due to MRI limitations and inconsistencies in interpretation. Understanding these variations is crucial for optimal patient management.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 45-55"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate Imaging Quality System Version 2 – A Practical Guide 前列腺图像质量系统 (PI-QUAL) 第 2 版 - 实用指南。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.006
Emily A. Knott , Ryan D. Ward , Daniel N. Costa , Francesco Giganti , Andrei S. Purysko
{"title":"Prostate Imaging Quality System Version 2 – A Practical Guide","authors":"Emily A. Knott ,&nbsp;Ryan D. Ward ,&nbsp;Daniel N. Costa ,&nbsp;Francesco Giganti ,&nbsp;Andrei S. Purysko","doi":"10.1053/j.sult.2024.11.006","DOIUrl":"10.1053/j.sult.2024.11.006","url":null,"abstract":"<div><div>High-quality prostate magnetic resonance imaging (MRI) is required for accurate prostate cancer detection, localization, and staging. Variability in image quality exists in practice, influenced by inconsistent adherence to technical standards, lack of patient preparation, variability in scanner performance, patient characteristics, and knowledge gaps in personnel scheduling and performing prostate MRI exams. The Prostate Imaging Quality (PI-QUAL) scoring system is a well-established tool for assessing the diagnostic quality of prostate MRI. An updated PI-QUAL version 2 was published in 2024 by a group of experts to address the limitations of the original system. This pictorial review highlights the key changes introduced in PI-QUAL version 2 and provides illustrative examples of each assessment category.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 83-89"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of MRI in Active Surveillance of Prostate Cancer MRI在前列腺癌主动监测中的作用。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.002
Meera R. Chappidi MD, MPH , Daniel W. Lin MD , Antonio C. Westphalen MD, PhD
{"title":"Role of MRI in Active Surveillance of Prostate Cancer","authors":"Meera R. Chappidi MD, MPH ,&nbsp;Daniel W. Lin MD ,&nbsp;Antonio C. Westphalen MD, PhD","doi":"10.1053/j.sult.2024.11.002","DOIUrl":"10.1053/j.sult.2024.11.002","url":null,"abstract":"<div><div>Magnetic resonance imaging (MRI) plays an important role in the management of patients with prostate cancer on active surveillance. In this review, we will explore the incorporation of MRI into active surveillance protocols, detailing its impact on clinical decision-making and patient management and discussing how it aligns with current guidelines and practice patterns. The role of MRI in this patient population continues to evolve over time, and we will discuss some of the recent advancements in the field and highlight potential areas for future research endeavors.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 31-44"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma – Anatomical Variations, Mimickers, and Post-Intervention Changes 解读前列腺多参数磁共振成像:腺癌之外--解剖变异、模仿者和干预后的变化。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.001
Enis C. Yilmaz , Omer Tarik Esengur , David G. Gelikman , Baris Turkbey MD
{"title":"Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma – Anatomical Variations, Mimickers, and Post-Intervention Changes","authors":"Enis C. Yilmaz ,&nbsp;Omer Tarik Esengur ,&nbsp;David G. Gelikman ,&nbsp;Baris Turkbey MD","doi":"10.1053/j.sult.2024.11.001","DOIUrl":"10.1053/j.sult.2024.11.001","url":null,"abstract":"<div><div>Prostate magnetic resonance imaging (MRI) is an essential tool in the diagnostic pathway for prostate cancer. However, its accuracy can be confounded by a spectrum of noncancerous entities with similar radiological features, posing a challenge for definitive diagnosis. This review synthesizes current knowledge on the MRI phenotypes of both common and rare benign prostate conditions that may be mistaken for malignancy. The narrative encompasses anatomical variants, other neoplastic processes, inflammatory conditions, and alterations secondary to medical interventions. Furthermore, this review underscores the critical role of MRI quality in diagnostic accuracy and explores the emerging contributions of artificial intelligence in enhancing image interpretation.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 2-30"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate Imaging for Recurrence Reporting System Made Easy: A Case-Based Review of Prostate Cancer Local Recurrence on Magnetic Resonance Imaging 前列腺成像复发报告系统变得简单:基于病例的磁共振成像前列腺癌局部复发回顾。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.004
Paulo de Moraes Antunes , Natalia Sabaneeff , Eduardo Thadeu de Oliveira Correia , Leonardo Kayat Bittencourt
{"title":"Prostate Imaging for Recurrence Reporting System Made Easy: A Case-Based Review of Prostate Cancer Local Recurrence on Magnetic Resonance Imaging","authors":"Paulo de Moraes Antunes ,&nbsp;Natalia Sabaneeff ,&nbsp;Eduardo Thadeu de Oliveira Correia ,&nbsp;Leonardo Kayat Bittencourt","doi":"10.1053/j.sult.2024.11.004","DOIUrl":"10.1053/j.sult.2024.11.004","url":null,"abstract":"<div><div>Prostate cancer (PCa) is one of the most prevalent cancers worldwide. Even following appropriate initial treatments, a subset of the patients develops tumor recurrence. Magnetic resonance imaging (MRI) is pivotal in investigating local recurrence, but its performance is limited in detecting recurrence at other sites (especially in subcentimeter lymph nodes). Recently, an expert consensus proposed a scoring system for MRI-based assessment of local recurrence, called prostate imaging for recurrence reporting system (PI-RR). This case-based review describes the expected post-treatment changes and MRI findings of local PCa recurrence after RP and RT.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 56-70"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Prostate-Specific Membrane Antigen-Radioligand and Magnetic Resonance Imaging in Patients with Prostate Cancer Biochemical Recurrence PSMA 抗原和磁共振成像在前列腺癌生化复发患者中的作用
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.005
Emily Abramczyk MD , Muhammad Umer Nisar MD , Jane K. Nguyen MD, PhD , Nicholas Austin DO , Ryan D. Ward MD, MBA , Christopher Weight MD , Andrei S. Purysko MD
{"title":"The Role of Prostate-Specific Membrane Antigen-Radioligand and Magnetic Resonance Imaging in Patients with Prostate Cancer Biochemical Recurrence","authors":"Emily Abramczyk MD ,&nbsp;Muhammad Umer Nisar MD ,&nbsp;Jane K. Nguyen MD, PhD ,&nbsp;Nicholas Austin DO ,&nbsp;Ryan D. Ward MD, MBA ,&nbsp;Christopher Weight MD ,&nbsp;Andrei S. Purysko MD","doi":"10.1053/j.sult.2024.11.005","DOIUrl":"10.1053/j.sult.2024.11.005","url":null,"abstract":"<div><div>A significant proportion of men with prostate cancer will experience biochemical recurrence (BCR), which is characterized by an elevation in prostate-specific antigen (PSA) levels after receiving treatment with curative intent. Imaging plays an important role in the management of patients with BCR. It can help identify sites of recurrence to determine the most appropriate management strategies, ranging from salvage treatment for local recurrences to systemic treatments for those with advanced, distant disease. PET/CT with prostate-specific membrane antigen (PSMA)-radioligands is the most sensitive method for the detection of prostate cancer recurrence, with significantly higher cancer detection rates compared to conventional imaging techniques such as bone scan and computed tomography, even at lower PSA levels. Nevertheless, interpretation of PSMA PET/CT images can be challenging, particularly for the evaluation of local recurrence due to urinary activity that can mimic or mask the presence of cancer. Furthermore, some prostate cancers may not express PSMA and have false negative results. Multiparametric prostate MRI is an excellent method for the evaluation of local recurrence and can overcome some of the limitations of PSMA PET/CT. In this review, we discuss the role of imaging in managing patients with prostate cancer BCR and describe the potential benefits of MRI in the PSMA-radioligand imaging era, emphasizing the assessment of local recurrence.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Pages 71-82"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter From the Guest Editor 特邀编辑的来信
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2025-02-01 DOI: 10.1053/j.sult.2024.11.007
Andrei S. Purysko MD
{"title":"Letter From the Guest Editor","authors":"Andrei S. Purysko MD","doi":"10.1053/j.sult.2024.11.007","DOIUrl":"10.1053/j.sult.2024.11.007","url":null,"abstract":"","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"46 1","pages":"Page 1"},"PeriodicalIF":1.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pitfalls in Positron Emission Tomography/Computed Tomography in the Thorax and Abdomen 胸部和腹部 PET/CT 的陷阱。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2024-12-01 DOI: 10.1053/j.sult.2024.07.012
Stephen L. Sartin MD , Dhanwin R. Shetty MD , Chad D. Strange MD , Gabriela Gayer MD , Jitesh Ahuja MD , Rishi Agrawal MD , Mylene T. Truong MD
{"title":"Pitfalls in Positron Emission Tomography/Computed Tomography in the Thorax and Abdomen","authors":"Stephen L. Sartin MD ,&nbsp;Dhanwin R. Shetty MD ,&nbsp;Chad D. Strange MD ,&nbsp;Gabriela Gayer MD ,&nbsp;Jitesh Ahuja MD ,&nbsp;Rishi Agrawal MD ,&nbsp;Mylene T. Truong MD","doi":"10.1053/j.sult.2024.07.012","DOIUrl":"10.1053/j.sult.2024.07.012","url":null,"abstract":"<div><div>Positron emission tomography/computed tomography (PET/CT) using [18F]-fluoro-2-deoxy-<span>D</span>-glucose (FDG) has become the mainstay imaging modality for evaluating oncology patients with certain cancers. The most common FDG PET/CT applications include staging/restaging, assessing response to therapy and detecting tumor recurrence. It is important to be aware of potential pitfalls and technical artifacts on PET/CT in the chest and abdomen to ensure accurate interpretation, avoid unnecessary intervention and optimize patient care.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"45 6","pages":"Pages 488-495"},"PeriodicalIF":1.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Ninth Edition TNM Staging Classification for Thymic Epithelial Tumors 第九版胸腺上皮肿瘤 TNM 分期分类。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2024-12-01 DOI: 10.1053/j.sult.2024.07.006
Vera Sorin MD , Zehavit Kirshenboim MD , Maximiliano Klug MD , Jitesh Ahuja MD , Edith M. Marom MD
{"title":"The Ninth Edition TNM Staging Classification for Thymic Epithelial Tumors","authors":"Vera Sorin MD ,&nbsp;Zehavit Kirshenboim MD ,&nbsp;Maximiliano Klug MD ,&nbsp;Jitesh Ahuja MD ,&nbsp;Edith M. Marom MD","doi":"10.1053/j.sult.2024.07.006","DOIUrl":"10.1053/j.sult.2024.07.006","url":null,"abstract":"<div><div>Staging classification is essential in cancer management and is based on three components: tumor extent (T), lymph node involvement (N), and distant metastatic disease (M). For thymic epithelial malignancies, clinical Tumour, Node, Metastasis (cTNM) staging is primarily determined by imaging, making radiologists integral to clinical practice, treatment decisions, and maintaining the quality of staging databases. The ninth edition of the TNM classification for thymic epithelial tumors will be implemented in January 2025. This review outlines the definitions for the TNM categories in the updated edition, provides examples, and elaborates on the radiologist’s role and imaging considerations.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"45 6","pages":"Pages 420-429"},"PeriodicalIF":1.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging of Lung Cancer Staging: TNM 9 Updates 肺癌分期成像:TNM 9 更新。
IF 1.5 4区 医学
Seminars in Ultrasound Ct and Mri Pub Date : 2024-12-01 DOI: 10.1053/j.sult.2024.07.005
Lauren T. Erasmus BSc , Chad D. Strange MD , Jitesh Ahuja MD , Rishi Agrawal MD , Girish S. Shroff MD , Edith M. Marom MD , Mylene T. Truong MD
{"title":"Imaging of Lung Cancer Staging: TNM 9 Updates","authors":"Lauren T. Erasmus BSc ,&nbsp;Chad D. Strange MD ,&nbsp;Jitesh Ahuja MD ,&nbsp;Rishi Agrawal MD ,&nbsp;Girish S. Shroff MD ,&nbsp;Edith M. Marom MD ,&nbsp;Mylene T. Truong MD","doi":"10.1053/j.sult.2024.07.005","DOIUrl":"10.1053/j.sult.2024.07.005","url":null,"abstract":"<div><div>Imaging plays a key role in clinical staging of lung cancer and guiding therapy. A thorough understanding of the staging system including the nomenclature and updates is necessary to tailor treatment plans and optimize patient care. The 9th edition of the Tumor, Node, Metastasis staging system for lung cancer has no changes for T classification and subdivides N2 and M1c categories. In nodal staging, N2 splits into N2a, ipsilateral mediastinal single station involvement and N2b, ipsilateral mediastinal multiple stations involvement. In the staging of multiple extrathoracic metastases, M1c splits into M1c1, multiple extrathoracic metastases in one organ system and M1c2, multiple extrathoracic metastases in multiple organ systems. Awareness of the proposed changes in TNM-9 staging classification is essential to provide methodical and accurate imaging interpretation.</div></div>","PeriodicalId":49541,"journal":{"name":"Seminars in Ultrasound Ct and Mri","volume":"45 6","pages":"Pages 410-419"},"PeriodicalIF":1.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信